Get started
Author

Craig L. Stephens

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer
2003 · Rafael Rosell, Giorgio Scagliotti, et al. · Oncogene · 188
Large-Scale Screening and Molecular Characterization of EML4-ALK Fusion Variants in Archival Non–Small-Cell Lung Cancer Tumor Specimens Using Quantitative Reverse Transcription Polymerase Chain Reaction Assays
2013 · Tianhong Li, Martin K.H. Maus, et al. · Journal of Thoracic Oncology · 61
PDF
Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer
2018 · Yu Sunakawa, Dongyun Yang, et al. · Clinical Colorectal Cancer · 31
Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients with Non–Small-Cell Lung Cancer: Implications for Therapy
2013 · Martin K.H. Maus, Philip C. Mack, et al. · Journal of Thoracic Oncology · 27
Thymidylate synthase (TS) gene expression in patients with ALK positive (+) non-small cell lung cancer (NSCLC): Implications for therapy.
2012 · David R. Gandara, Eric Huang, et al. · Journal of Clinical Oncology · 17
Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer
2016 · Yu Sunakawa, Dongyun Yang, et al. · Cancer Biology & Therapy · 16
PDF
AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth
2016 · Brian R. Hu, Adrian S. Fairey, et al. · The Prostate · 16
Identification of Novel Variant of EML4-ALK Fusion Gene in NSCLC: Potential Benefits of the RT-PCR Method
2012 · Martin K. H. Maus, Peter P. Grimminger, et al. · International Journal of Biomedical Science · 13
Identification of Novel Variant of EML4-ALK Fusion Gene in NSCLC: Potential Benefits of the RT-PCR Method.
2012 · Martin K H Maus, Craig Stephens, et al. · PubMed · 13
1031 Down staging of T3 rectal cancer after preoperative infusional chemoradiation is correlated with spontaneous apoptosis index and BCL-2 staining
1996 · T.A. Rich, F. Sinicrope, et al. · International Journal of Radiation Oncology*Biology*Physics · 13
Gene expression profiles and tumor locations in colorectal cancer (left vs. right vs. rectum).
2013 · Martin K. H. Maus, Diana L. Hanna, et al. · Journal of Clinical Oncology · 11
Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
2016 · Stefan Stremitzer, Wu Zhang, et al. · Molecular Cancer Therapeutics · 9
Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
2018 · Yu Sunakawa, Kaoru Mogushi, et al. · Molecular Cancer Therapeutics · 7
Carbenoid Reactions of 2-Halomethyl-4,6-dimethyl-s-triazines
2002 · Craig L. Stephens, H. LeRoy Nyquist, et al. · The Journal of Organic Chemistry · 7
Phase II study of dovitinib in patients (Pts) progressing on anti-vascular endothelial growth factor (VEGF) therapy.
2016 · Thomas John Semrad, Edward Jae-hoon Kim, et al. · Journal of Clinical Oncology · 5
Update on the large-scale screening of ALK fusion oncogene transcripts in archival NSCLC tumor specimens using multiplexed RT-PCR assays.
2012 · Tianhong Li, Eric Huang, et al. · Journal of Clinical Oncology · 5
C-MET mRNA expression in pancreatic ductal adenocarcinoma and stromal tissue: Prognostic and therapeutic implications.
2014 · Martin K. H. Maus, Craig Stephens, et al. · Journal of Clinical Oncology · 4
Effect of AXIN2 expression on prostate cancer recurrence and an invasive, tumorigenic phenotype.
2015 · Brian Robin Hu, Adrian S Fairey, et al. · Journal of Clinical Oncology · 3
C-kit mRNA expression in pancreatic adenocarcinoma and matched stromal tissue: Prognostic and therapeutic implications.
2014 · Peter Philipp Grimminger, Craig Stephens, et al. · Journal of Clinical Oncology · 1
A biomarker study to validate predictors for clinical outcome of cetuximab based chemotherapy in first-line metastatic colorectal cancer (mCRC) patients: JACCRO CC-05/06AR and FIRE-3
2018 · Y. Sunakawa, S. Stintzing, et al. · Annals of Oncology
AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth.
2015 · Brian Robin Hu, Adrian S Fairey, et al. · Journal of Clinical Oncology
Validation of ERCC1 (E1) for response prediction to platinum-gemcitabine.
2015 · Gerold Bepler, Wei Chen, et al. · Journal of Clinical Oncology
Mp37-19 Axin2 Expression Predicts Prostate Cancer Recurrence and Mediates an Invasive, Tumorigenic Phenotype
2015 · Brian Hu, Adrian Fairey, et al. · The Journal of Urology
KRAS screening for clinically important mutants via a multiplex allele-specific PCR assay for exons 2, 3, and 4.
2014 · Garrett Larson, Craig Stephens, et al. · Journal of Clinical Oncology
Mp41-09 Axin2 Predicts Prostate Cancer Recurrence After Radical Prostatectomy
2014 · Brian Hu, Adrian Fairey, et al. · The Journal of Urology
Works count: 32
Citation count: 447
H-index: 11
I10-index: 11
Year
Topic
Type